MRI can detect 90 percent of breast cancers

Share this content:

the ONA take:

A recent study has determined that approximately 90 percent of breast cancers can be diagnosed via magnetic resonance imaging (MRI). 

The research team, based at the University Department of Radiology and Nuclear Medicine at the MedUni Vienna, in cooperation with the University Department of Gynaecology and Obstetrics and the Clinical Institute of Pathology, compared results from mammography, ultrasound, and MRI testing.

Records from 559 women with breast cancer were reviewed, which totaled 1,365 screening tests. Ultrasound alone was not useful in detecting the breast cancer, whereas MRI clearly established the presence of breast cancer approximately 90 percent of the time.

The addition of mammography screen to MRI increased detection by approximately 5 percent. Screening results for the various methods to detect benign lesions was comparable. Results were also unaffected by the variables of gene mutation, age of the patient, or degree of breast density.

Study leaders Thomas Helbich and Christopher Riedl feel the results should serve as a call for increased use of NRI for breast cancer detection, and that high-risk individuals with a family history of breast cancer should opt for yearly MRI testing.

The current EU ratio is 10 MRI scanners per one million inhabitants, a somewhat low ratio if MRI testing were to be increased. 

Study findings were published in the Journal of Clinical Oncology.

MRI can detect 90% of breast cancers
A recent study has determined that approximately 90 percent of breast cancers can be diagnosed via MRI.
Breast cancer screening: 90 percent of all cancers can be detected with MRI Around 90 per cent of all breast cancers can be definitively diagnosed using magnetic resonance imaging (MRI).
READ FULL ARTICLE From Medical Express
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs